Cholesterol clinical trials at UCSF

2 in progress, 0 open to eligible people

Showing trials for

  • Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

    Sorry, not currently recruiting here

    This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 6 to <12 years) with heterozygous familial hypercholesterolemia (HeFH) and elevated low density lipoprotein cholesterol (LDLC).

    San Francisco, California and other locations

  • Inclisiran in Children With Homozygous Familial Hypercholesterolemia

    Sorry, not currently recruiting here

    This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to <12 years) with homozygous familial hypercholesterolemia (HoFH) and elevated low density lipoprotein cholesterol (LDLC).

    San Francisco, California and other locations

Our lead scientists for Cholesterol research studies include .

Last updated: